Diagnostic anti-Sodium valproate (VPA) antibodies (anti-Sodium valproate, anti-VPA) and diagnostic hapten-carrier conjugates BSA-Sodium valproate (VPA), OVA-Sodium valproate (VPA), KLH-Sodium valproate (VPA) antigens for Epilepsy VPA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Epilepsy (toxicity) and related syndrome. GeneMedi offers paired anti-Sodium valproate (VPA) antibodies (monoclonal antibody, mab) and Sodium valproate (VPA antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Epilepsy (toxicity) rapid test kit of Sodium valproate (VPA) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.Valproate (VPA) and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. They are useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures. They can be given intravenously or by mouth, and the tablet forms exist in both long- and short-acting formulations.